Drug Search Results
More Filters [+]

Olprinone

Alternative Names: olprinone
Latest Update: 2024-03-20
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PDE3 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Fudan University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Olprinone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Acute Lung Injury|Acute Respiratory Distress Syndrome|Respiratory Distress Syndrome, Newborn

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2200055129

N/A

Recruiting

Heart Failure, Acute

2024-10-12

PETARDS

P4

Unknown status

Respiratory Distress Syndrome, Newborn|Acute Lung Injury|Acute Respiratory Distress Syndrome

2023-10-01

Recent News Events